Macrophage Activation Syndrome Revealing Hodgkin Lymphoma: A Pediatric Case Report
- PMID: 40416268
- PMCID: PMC12103714
- DOI: 10.7759/cureus.82962
Macrophage Activation Syndrome Revealing Hodgkin Lymphoma: A Pediatric Case Report
Abstract
Secondary macrophage activation syndrome is a severe and rare complication of infectious, autoimmune, and malignant diseases. Herein, we report the case of a 10-year-old child with this syndrome leading to the discovery of Hodgkin lymphoma. The patient, who had a medical history of cerebral palsy and ataxia-telangiectasia syndrome, was admitted for prolonged fever associated with cough, which had evolved into general health deterioration for two months prior to admission. He received multiple courses of antibiotic therapy for suspected pneumonia without clinical improvement. Clinical examination showed pallor, deteriorated general condition, high fever, asthenia, cervical adenopathy, and splenomegaly. The clinical and biological criteria led to the diagnosis of macrophage activation syndrome. Lymph node histology confirmed the diagnosis of Hodgkin lymphoma, which was staged as stage IV via positron emission tomography scan. The "vincristine, etoposide, prednisone, and doxorubicin" (OEPA) chemotherapy regimen was initiated, followed by the "cyclophosphamide, vincristine, prednisone, and dacarbazine" (COPDAC) regimen, with remission achieved both clinically and paraclinically after one cycle of each regimen.
Keywords: adenopathy; fever; histology; hodgkin lymphoma; macrophage activation syndrome.
Copyright © 2025, Hared Bouh et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.J Clin Oncol. 2010 Aug 10;28(23):3680-6. doi: 10.1200/JCO.2009.26.9381. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625128
-
Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol.Hum Reprod. 2024 Nov 1;39(11):2411-2422. doi: 10.1093/humrep/deae204. Hum Reprod. 2024. PMID: 39256932 Free PMC article. Clinical Trial.
-
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.Hum Reprod. 2024 Aug 1;39(8):1701-1711. doi: 10.1093/humrep/deae112. Hum Reprod. 2024. PMID: 38794915 Free PMC article.
-
Lymphoma: Diagnosis and Treatment.Am Fam Physician. 2020 Jan 1;101(1):34-41. Am Fam Physician. 2020. PMID: 31894937 Review.
-
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.J Med Case Rep. 2018 May 30;12(1):151. doi: 10.1186/s13256-018-1693-0. J Med Case Rep. 2018. PMID: 29843820 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources